SUBSCRIBERS
Cordlife to buy cord blood bank HealthBaby
Published Wed, Jan 3, 2018 · 09:50 PM
Singapore
IN a bid to expand its presence in Hong Kong and Macau, Singapore-listed consumer healthcare company Cordlife Group has signed an agreement to buy out private cord blood bank HealthBaby Biotech (Hong Kong) Co from Stemgen Biotech Holding.
As part of the transaction, Cordlife will assume the debt of HK$138.2 million (S$23.8 million) which Stemgen Biotech Holding owed to HealthBaby Hong Kong.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Apple nears deal with OpenAI to put ChatGPT on iPhone
Why companies are nervous about the consumer
Apple says no major app developers accept new outside payments
Shein steps up London IPO preparations amid US hurdles to listing, sources say
Apple scores win in labor case involving fired retail workers
US: Stocks closes up another weekly gain ahead of inflation data